BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20160274)

  • 1. Accuracy of perceived risk of recurrence among patients with early-stage breast cancer.
    Liu Y; Pérez M; Aft RL; Massman K; Robinson E; Myles S; Schootman M; Gillanders WE; Jeffe DB
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):675-80. PubMed ID: 20160274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer.
    Liu Y; Pérez M; Schootman M; Aft RL; Gillanders WE; Ellis MJ; Jeffe DB
    Breast Cancer Res Treat; 2010 Dec; 124(3):835-44. PubMed ID: 20446031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer.
    Liu Y; Pérez M; Schootman M; Aft RL; Gillanders WE; Jeffe DB
    Breast Cancer Res Treat; 2011 Nov; 130(1):165-73. PubMed ID: 21553295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study.
    Portschy PR; Abbott AM; Burke EE; Nzara R; Marmor S; Kuntz KM; Tuttle TM
    Ann Surg Oncol; 2015 Nov; 22(12):3846-52. PubMed ID: 25762480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
    Partridge A; Adloff K; Blood E; Dees EC; Kaelin C; Golshan M; Ligibel J; de Moor JS; Weeks J; Emmons K; Winer E
    J Natl Cancer Inst; 2008 Feb; 100(4):243-51. PubMed ID: 18270338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer.
    Rakovitch E; Franssen E; Kim J; Ackerman I; Pignol JP; Paszat L; Pritchard KI; Ho C; Redelmeier DA
    Breast Cancer Res Treat; 2003 Feb; 77(3):285-93. PubMed ID: 12602928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of contralateral breast cancer: an overestimation of risk.
    Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
    Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of cancer recurrence risk: more information is better.
    Kelly KM; Ajmera M; Bhattacharjee S; Vohra R; Hobbs G; Chaudhary L; Abraham J; Agnese D
    Patient Educ Couns; 2013 Mar; 90(3):361-6. PubMed ID: 22231022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
    Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worry about cancer progression and low perceived social support: implications for quality of life among early-stage breast cancer patients.
    Waters EA; Liu Y; Schootman M; Jeffe DB
    Ann Behav Med; 2013 Feb; 45(1):57-68. PubMed ID: 22983622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence.
    Janz NK; Li Y; Zikmund-Fisher BJ; Jagsi R; Kurian AW; An LC; McLeod MC; Lee KL; Katz SJ; Hawley ST
    Breast Cancer Res Treat; 2017 Feb; 161(3):525-535. PubMed ID: 27943007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?
    Lee KL; Janz NK; Zikmund-Fisher BJ; Jagsi R; Wallner LP; Kurian AW; Katz SJ; Abrahamse P; Hawley ST
    Med Decis Making; 2018 Jan; 38(1):95-106. PubMed ID: 28814131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.
    Habel LA; Achacoso NS; Haque R; Nekhlyudov L; Fletcher SW; Schnitt SJ; Collins LC; Geiger AM; Puligandla B; Acton L; Quesenberry CP
    Breast Cancer Res; 2009; 11(6):R85. PubMed ID: 19922614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ.
    van Gestel YR; Voogd AC; Vingerhoets AJ; Mols F; Nieuwenhuijzen GA; van Driel OJ; van Berlo CL; van de Poll-Franse LV
    Eur J Cancer; 2007 Feb; 43(3):549-56. PubMed ID: 17140788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for breast cancer mortality after ductal carcinoma in situ diagnosis differ from those for invasive recurrence.
    O'Keefe TJ; Chau H; Harismendy O; Wallace AM
    Surgery; 2023 Feb; 173(2):305-311. PubMed ID: 36435650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worry about breast cancer recurrence: a population-based analysis.
    Tewari A; Chagpar AB
    Am Surg; 2014 Jul; 80(7):640-5. PubMed ID: 24987893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial distress affecting patients with ductal carcinoma in situ compared to patients with early invasive breast cancer.
    Sanders JB; Loftin A; Seda JS; Ehlenbeck C
    Clin J Oncol Nurs; 2014 Dec; 18(6):684-8. PubMed ID: 25427702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy.
    Abner AL; Connolly JL; Recht A; Bornstein B; Nixon A; Hetelekidis S; Silver B; Harris JR; Schnitt SJ
    Cancer; 2000 Mar; 88(5):1072-7. PubMed ID: 10699897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
    Thompson AM; Clements K; Cheung S; Pinder SE; Lawrence G; Sawyer E; Kearins O; Ball GR; Tomlinson I; Hanby A; Thomas JSJ; Maxwell AJ; Wallis MG; Dodwell DJ;
    Eur J Cancer; 2018 Sep; 101():210-219. PubMed ID: 30092498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.